Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Ghiringhelli

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2014
Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based studyFrancois Ghiringhelli, Audrey Hennequin, Antoine Drouillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2018
Reply to M. Mo et alThomas Aparicio, Francois Ghiringhelli, Valerie Boige, et al.
Anti-Cancer Drugs|March 11, 2010
Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective studyCedric Khouri, Boris Guiu, Jean Pierre Cercueil, et al.
World Journal of Gastrointestinal Oncology|August 23, 2019
Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective studyValeria Basso, David Orry, Jean Fraisse, et al.
BMC Cancer|August 12, 2020
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatmentJean-David Fumet, Emeric Limagne, Marion Thibaudin, et al.
Oncotarget|June 8, 2018
Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinomaAnne Aarnink, Corentin Richard, Caroline Truntzer, et al.
Journal for Immunotherapy of Cancer|June 4, 2021
Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancerQuentin Klopfenstein, Valentin Derangère, Laurent Arnould, et al.
Plos One|March 26, 2013
Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig modelPierre-Benoit Pagès, Olivier Facy, Pierre Mordant, et al.
Current Opinion in Immunology|June 25, 2008
Immunogenic cancer cell death: a key-lock paradigmAntoine Tesniere, Lionel Apetoh, Francois Ghiringhelli, et al.
Annals of Surgery|May 29, 2012
High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental studyOlivier Facy, Sophie Al Samman, Guy Magnin, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2014
Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based studyFrancois Ghiringhelli, Audrey Hennequin, Antoine Drouillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2018
Reply to M. Mo et alThomas Aparicio, Francois Ghiringhelli, Valerie Boige, et al.
Anti-Cancer Drugs|March 11, 2010
Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective studyCedric Khouri, Boris Guiu, Jean Pierre Cercueil, et al.
World Journal of Gastrointestinal Oncology|August 23, 2019
Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective studyValeria Basso, David Orry, Jean Fraisse, et al.
BMC Cancer|August 12, 2020
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatmentJean-David Fumet, Emeric Limagne, Marion Thibaudin, et al.
Oncotarget|June 8, 2018
Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinomaAnne Aarnink, Corentin Richard, Caroline Truntzer, et al.
Journal for Immunotherapy of Cancer|June 4, 2021
Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancerQuentin Klopfenstein, Valentin Derangère, Laurent Arnould, et al.
Plos One|March 26, 2013
Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig modelPierre-Benoit Pagès, Olivier Facy, Pierre Mordant, et al.
Current Opinion in Immunology|June 25, 2008
Immunogenic cancer cell death: a key-lock paradigmAntoine Tesniere, Lionel Apetoh, Francois Ghiringhelli, et al.
Annals of Surgery|May 29, 2012
High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental studyOlivier Facy, Sophie Al Samman, Guy Magnin, et al.
Pageof 10